Sanofi (SNY) — Hedge Fund Ownership Q1 2026
SNY
- Sanofi (SNY) is held by 4 of 82 tracked hedge funds, with Dodge & Cox (1%) and Causeway Capital Management (1%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in SNY holdings came from Pzena Investment Management (+62%) and Causeway Capital Management (+0.1%), highlighting conviction.
- The biggest decreases in SNY holdings came from Dodge & Cox (-48%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to Sanofi (SNY) by -47% vs the prior quarter and -59% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Dodge & Cox
|
0.78% | 29.5M | -47.77% | -59.69% | $1.42B | $48.18 | — |
| 2 |
Causeway Capital Management
|
0.63% | 1.1M | +0.05% | +53.55% | $51.3M | $48.18 | — |
| 3 |
Maverick Capital Lee Ainslie
|
0.01% | 25K | NEW | — | $1.2M | $48.18 | — |
| 4 |
Pzena Investment Management Richard Pzena
|
0.00% | 19K | +62.46% | +254.47% | $919,636 | $48.18 | — |
| 4 | Total | — | 30.6M | -46.87% | -58.60% | $1.47B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.